Icon

MIRVASO (nda204708)- (EQ 0.33% BASE)

BRIMONIDINE TARTRATE GALDERMA LABS LP
EQ 0.33% BASE
Yes Yes
2031-Jun-13 Expired
None None
None No
MIRVASO (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.
1 0 1
Total Other Developers None
Drugs with Suitability No
EQ 0.33% BASE ** ** - - 1
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ****** *************** *** *********** * ********* ***, *******, *******, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.